Actualités ABIOMED Inc - ABMD | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission December 22, 2022 Registration...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission December 22, 2022 Registration...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission December 22, 2022 Registration...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission December 22, 2022 Registration...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission December 22, 2022 Registration...

Current Report Filing (8-k)

ABIOMED INC false 0000815094 --03-31 0000815094 2022-12-22 2022-12-22 UNITED STATES SECURITIES...

Amended Tender Offer Statement by Third Party (sc To-t/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (Amendment...

Amended Statement of Ownership: Solicitation (sc 14d9/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment...

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER...

La FDA approuve la pompe cardiaque Impella ECP et les premiers patients sont recrutés dans un essai clinique pivot

Abiomed (Nasdaq : ABMD) annonce que la Food and Drug Administration (FDA) américaine a approuvé la version de...

Impella ECP-Herzpumpe erhält FDA-Zulassung – erste Patienten in zulassungsrelevante klinische Studie aufgenommen

Abiomed (NASDAQ: ABMD) gibt die Zulassung der Impella ECP durch die US-amerikanische Food and Drug...

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400

Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK, Dec. 19, 2022 NEW YORK, Dec. 19...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ABIOMED Inc (ABMD)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

ABMD Actualités

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Current Report Filing (8-k)

Amended Tender Offer Statement by Third Party (sc To-t/a)

Amended Statement of Ownership: Solicitation (sc 14d9/a)

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

La FDA approuve la pompe cardiaque Impella ECP et les premiers patients sont recrutés dans un essai clinique pivot

Impella ECP-Herzpumpe erhält FDA-Zulassung – erste Patienten in zulassungsrelevante klinische Studie aufgenommen

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ABIOMED Inc (ABMD) Actualités

ABIOMED Inc (ABMD)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

ABMD Actualités

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Current Report Filing (8-k)

Amended Tender Offer Statement by Third Party (sc To-t/a)

Amended Statement of Ownership: Solicitation (sc 14d9/a)

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

La FDA approuve la pompe cardiaque Impella ECP et les premiers patients sont recrutés dans un essai clinique pivot

Impella ECP-Herzpumpe erhält FDA-Zulassung – erste Patienten in zulassungsrelevante klinische Studie aufgenommen

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application